Rapid development of API nano-formulations from screening to production combining dual centrifugation and wet agitator bead milling
- 1 June 2019
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 565, 187-198
Abstract
No abstract availableKeywords
Funding Information
- Albert-Ludwig-University Freiburg
- Untersuchungsinstitut Heppeler GmbH
This publication has 31 references indexed in Scilit:
- Optimization of formulation and process variable of nanosuspension: An industrial perspectiveInternational Journal of Pharmaceutics, 2010
- Study of the process of stirred ball milling of poorly water soluble organic products using factorial designPowder Technology, 2010
- Downscaling Drug Nanosuspension Production: Processing Aspects and Physicochemical CharacterizationAAPS PharmSciTech, 2009
- Nanosizing — Oral formulation development and biopharmaceutical evaluationAdvanced Drug Delivery Reviews, 2007
- Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugsInternational Journal of Pharmaceutics, 2006
- Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogsJournal of Controlled Release, 2006
- Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006
- Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in ratsInternational Journal of Pharmaceutics, 1995
- The relationship between particle size and solubilityInternational Journal of Pharmaceutics, 1992
- Inhibition of Sulfathiazole Crystal Growth by PolyvinylpyrrolidoneJournal of Pharmaceutical Sciences, 1970